{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:24:14Z","timestamp":1791239054927,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1067\/mai.2003.168","type":"journal-article","created":{"date-parts":[[2003,4,7]],"date-time":"2003-04-07T20:20:55Z","timestamp":1049746855000},"page":"617-622","source":"Crossref","is-referenced-by-count":104,"title":["Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis"],"prefix":"10.1067","volume":"111","author":[{"given":"F.Estelle R.","family":"Simons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Prenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Albert","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2003.168_bib1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.46.12.895","article-title":"Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history","volume":"46","author":"Sibbald","year":"1991","journal-title":"Thorax"},{"key":"10.1067\/mai.2003.168_bib2","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.168_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1081-1206(10)63152-3","article-title":"Diagnosis and management of rhinitis: parameter documents of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2003.168_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0091-6749(00)90068-X","article-title":"Molecular pathology of allergic disease. II: Upper airway disease","volume":"105","author":"Christodoulopoulos","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.168_bib5","first-page":"179","article-title":"Antihistamines in rhinoconjunctivitis","author":"Howarth","year":"2002"},{"key":"10.1067\/mai.2003.168_bib6","first-page":"345","article-title":"Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist: 1st communication: receptor selectivity, antihistaminic activity, and anti-allergenic effects","volume":"50","author":"Kreutner","year":"2000","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"10.1067\/mai.2003.168_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1067\/mai.2001.114239","article-title":"Desloratadine: a new, nonsedating, oral antihistamine","volume":"107","author":"Geha","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl 1","key":"10.1067\/mai.2003.168_bib8","first-page":"1","article-title":"Desloratadine: clinical pharmacokinetics of a novel H1-receptor antagonist","volume":"41","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1067\/mai.2003.168_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00044011-200121010-00004","article-title":"Efficacy and tolerability of once-daily 5 mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis: assessment during the spring and fall allergy seasons","volume":"21","author":"Meltzer","year":"2001","journal-title":"Clin Drug Invest"},{"key":"10.1067\/mai.2003.168_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1034\/j.1398-9995.2001.00082.x","article-title":"Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis","volume":"56","author":"Nayak","year":"2001","journal-title":"Allergy"},{"issue":"suppl 65","key":"10.1067\/mai.2003.168_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1034\/j.1398-9995.2001.00102.x","article-title":"Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis","volume":"56","author":"Bachert","year":"2001","journal-title":"Allergy"},{"key":"10.1067\/mai.2003.168_bib12","first-page":"141","article-title":"Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis","volume":"73","author":"Grossman","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2003.168_bib13","first-page":"348","article-title":"Efficacy and safety of cetirizine therapy in perennial allergic rhinitis","volume":"68","author":"Mansmann","year":"1992","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2003.168_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1081-1206(10)62991-2","article-title":"Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis","volume":"80","author":"Murris-Espin","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2003.168_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0091-6749(96)70155-0","article-title":"Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire","volume":"98","author":"Bousquet","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.168_bib16","first-page":"615","article-title":"Ebastine in perennial allergic rhinitis","volume":"67","author":"Picado Valles","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2003.168_bib17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1034\/j.1398-9995.1999.00984.x","article-title":"A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group","volume":"54","author":"Bousquet","year":"1999","journal-title":"Allergy"},{"key":"10.1067\/mai.2003.168_bib18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1034\/j.1398-9995.2001.00191.x","article-title":"Fexofenadine reduces nasal congestion in perennial allergic rhinitis","volume":"56","author":"Ciprandi","year":"2001","journal-title":"Allergy"},{"key":"10.1067\/mai.2003.168_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0091-6749(89)90127-9","article-title":"Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis","volume":"83","author":"Bruttmann","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.168_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1398-9995.1990.tb00493.x","article-title":"A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis","volume":"45","author":"Frolund","year":"1990","journal-title":"Allergy"},{"key":"10.1067\/mai.2003.168_bib21","first-page":"101","article-title":"Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis","volume":"34","author":"Bellioni","year":"1996","journal-title":"Rhinology"},{"key":"10.1067\/mai.2003.168_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.1998.tb03798.x","article-title":"Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group","volume":"53","author":"Bachert","year":"1998","journal-title":"Allergy"},{"key":"10.1067\/mai.2003.168_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-2222.2000.00749.x","article-title":"Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow","volume":"30","author":"Wilson","year":"2000","journal-title":"Clin Exp Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902914879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902914879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T20:57:08Z","timestamp":1553374628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674902914879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0091674902914879"],"URL":"https:\/\/doi.org\/10.1067\/mai.2003.168","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}